About Sirnaomics
Sirnaomics is a company based in Gaithersburg (United States) founded in 2007. Sirnaomics has raised $267 million across 17 funding rounds from investors including Maryland.gov, HHS and Bloomage Biotechnology. The company has 69 employees. Sirnaomics operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BridgeBio, BeiGene and Advanced Accelerator Applications, among others.
- Headquarter Gaithersburg, United States
- Employees 69
- Stage Public
- SectorsHealthcareTechnology
- Website category Health · Biotechnology and Pharmaceuticals
- Website sirnaomics.com
- Social LinkedIn
- Legal Name Sirnaomics Ltd.
- Net Profit-$14.43 M (USD)71.99as on Dec 31, 2025
- EBITDA-$13.53 M (USD)56.75as on Dec 31, 2025
- Total Equity Funding$267M (USD)
in 17 rounds
- Latest Funding Round$17.69M (USD), Post-IPO
Sep 2025
- InvestorsMaryland.gov
& 14 more
- Employee Count69
Funding Insights of Sirnaomics
Sirnaomics has successfully raised a total of $267M across 17 strategic funding rounds. The most recent funding activity was a Post-IPO round of $17.69 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $267M
- Total Rounds 17
- Last Round Post-IPO — $17.69M
- Investors Count 15
Latest 10 of 17 funding rounds of Sirnaomics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2025 | $17.69M | Post-IPO | – | – | |
| Jul 2021 | $105M | Series E | – | Rotating Boulder Fund | – |
| Oct 2020 | $105M | Series D | – | Rotating Boulder Fund, Walvax | |
| Jul 2019 | $25M | Series C | – | Yuexiu Group | |
| Apr 2019 | $22M | Series C | – | – | |
| Apr 2016 | $10M | Series B | – | – | – |
| Jun 2012 | – | Grant | – | – | |
| Apr 2012 | $221,350 | Grant | – | – | |
| Mar 2012 | $221,350 | Grant | – | – | |
| Aug 2010 | $234,390 | Grant | – | – |
15 investors in total: 15 institutional.
Investors in Sirnaomics
Sirnaomics has secured backing from 15 investors, including venture fund and institutional investors. Prominent investors backing the company include Maryland.gov, HHS and Bloomage Biotechnology.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity firm | – | tntpower.com | Shenzhen, China | |
A venture capital firm focused on life sciences investments. | – | sangelvc.com | Shenzhen, China | |
Venture capital firm investing in blockchain industry | – | longmen.fund | - | |
- | – | sangelbiomedicalventurecapital.tcc.mode | - | |
- | – | huakongequityinvestment.tcc.mode | - | |
- | – | qianhaishenghuiinvestment.tcc.mode | - | |
- | – | rich-yield-capital.com | - | |
- | – | sbir.nih.gov | - | |
Chinese vaccine manufacturer specializing in vaccines for meningitis and influenza | 2001 | walvax.com | Kunming, China | |
- | – | htcapital.org | - |
Investor details for Sirnaomics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Sirnaomics
12 people are tracked at Sirnaomics (11 in leadership, 1 in team); the tracked headcount is 69.
| Name | Role | Group |
|---|---|---|
Adrian Knoth | Director | Leadership |
Edward Wang | VP, Regulatory Compliance & CTO, China | Leadership |
Xianbin Yang | VP, Chief Scientific Officer - China | Leadership |
Alice Zhang | Program Operation Director, Assistance Treasury | Leadership |
Dai Xiaochang | Executive Director & Chief Strategy Officer | Leadership |
Nigel Yip | Chief Financial Officer | Leadership |
Patrick Y. Lu | Chairman, President & CEO | Leadership |
Yip Wing Kei | VP, Corporate Finance & CFO, China | Leadership |
Jacqueline A. Dombroski | VP, Regulatory Affairs | Leadership |
Jason Lok | Chief Financial Officer | Leadership |
Ashley Gaba | Associate Director, Regulatory Affairs/regulatory Operations | Leadership |
George Ji | Business Administrator | Team |
Complete people profiles for Sirnaomics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Sirnaomics
Sirnaomics is a publicly listed company on the HKEX with ticker symbol 2257 in Hong Kong, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date30 Dec 2021
- Listed onHKG: 2257
- Listed entitySirnaomics Ltd.
- Exchange sectorHealth technology
- ISINKYG2050P1028
- Share price3.79 HKD (+1.07% on the day) · 2026-10-09
- Market capitalisation425,636,365.00 HKD
- EPS (diluted, trailing year)-0.87 HKD
- Volume (last session)10,800
Financials of Sirnaomics
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | – | -112.3M HKD | -105.3M HKD |
| 2024 | 13.9M HKD | -400.9M HKD | -243.5M HKD |
| 2023 | – | -616.1M HKD | -558.9M HKD |
| 2022 | – | -691.4M HKD | -688.3M HKD |
| 2021 | – | -1.66B HKD | -428.8M HKD |
Detailed financial statements for Sirnaomics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Sirnaomics
4 dated milestones of Sirnaomics across 18 years, from founding to its latest funding, stage changes and deals.
- Founded Sirnaomics is founded.
- Funding First funding round.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $17.7M.
Competitors of Sirnaomics
Sirnaomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BridgeBio, BeiGene and Advanced Accelerator Applications, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| modernatx.com | 2010 | Cambridge, United States | $2.78B | 1,312 | mRNA-based therapeutics for diseases including cancer and infections are developed. | |
| jazzpharma.com | 2003 | Dublin, Ireland | $265M | 2,800 | Novel biopharmaceutical medicines are developed for unmet medical needs. | |
| bridgebio.com | 2015 | Palo Alto, United States | $434.2M | – | Therapeutics for genetic diseases are developed through targeted interventions. | |
| beigene.com | 2010 | Cambridge, United States | $172M | 1,090 | Targeted and immune-oncology drugs for cancer treatment are developed. | |
| adacap.com | 2002 | Saint Genis Pouilly, France | $56.13M | – | Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed. | |
| sparktx.com | 2013 | Philadelphia, United States | $82.8M | 822 | Gene therapies for rare diseases including retinal dystrophies are developed. | |
| alnylam.com | 2002 | Cambridge, United States | $17M | 2,100 | RNA interference-based therapeutics are developed for multiple disorders. | |
| atai.life | 2018 | Munich, Germany | $386.67M | – | A biopharmaceutical company accelerating innovative mental health treatments. | |
| insitro.com | 2018 | San Francisco, United States | $643.21M | 257 | An AI-enabled platform is developed for infectious disease treatment. |
Detailed competitors of Sirnaomics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Sirnaomics
The website of Sirnaomics (sirnaomics.com) receives about 1.9K visits a month and ranks #8,322,653 among all websites worldwide, #7,335 in Biotechnology and Pharmaceuticals.
- Monthly visits1.9K
▲ 1.5% vs previous month
- Global rank#8,322,653
among all websites
- Category rank#7,335
Health · Biotechnology and Pharmaceuticals
- Bounce rate43%
- Pages per visit1.8
- Average visit35 sec
- DevicesDesktop 35% · Mobile 65%
Websites whose visitors overlap most with Sirnaomics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| hspharm.com | 100% | 53.3K | #346,881 | View details | |
| phaserx.com | 87% | – | – | View details | |
genscript.jp | genscript.jp | 87% | – | #1,512,314 | – |
marinabio.com | marinabio.com | 86% | – | – | – |
| orbusneich.com | 56% | 9K | #2,415,384 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 8 similar websites and full traffic analytics for Sirnaomics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Sirnaomics
Complete news archive for Sirnaomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Sirnaomics
10 companies that operate in the same segment as Sirnaomics (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sirnaomics
Sirnaomics was founded in 2007.
Sirnaomics is headquartered in Gaithersburg, United States. It is registered at Gaithersburg, Maryland, United States.
Sirnaomics is a funded company, having raised a total of $267M across 17 funding rounds to date. The company's 1st funding round was a Grant of $234.39K, raised on Dec 2007.
Sirnaomics has 69 employees.
Sirnaomics was founded in 2007 and is located in Gaithersburg, United States. RNA-based therapeutics are developed for cancer and fibrosis treatment within the biotechnology sector. Proprietary delivery technologies, including a polypeptide nanoparticle RNAi platform and the GalNAc RNAi platform known as GalAhead, are employed to advance a drug candidate pipeline. This pipeline targets cardiovascular disease, cancers, skin conditions, fibrosis-related diseases, antiviral applications, cardiometabolic conditions, and medical aesthetics.
Sirnaomics's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
Yes, Sirnaomics is publicly traded on HKEX under the ticker symbol 2257.
Sirnaomics has 15 investors. Key investors include Maryland.gov, HHS, Bloomage Biotechnology, Yuexiu Group, and Walvax.
Sirnaomics operates through Sirnaomics, Inc.